Skip to main content
Top
Published in: Trials 1/2024

Open Access 01-12-2024 | Study protocol

Study protocol for a randomized controlled trial of the Parent–Child Assistance Program: a case management and home visiting program for people using substances during pregnancy

Authors: Erin J. Maher, Susan A. Stoner, Julie Gerlinger, A. C. Ferraro, Heather Lepper-Pappan

Published in: Trials | Issue 1/2024

Login to get access

Abstract

Background

Perinatal substance use can have significant adverse effects on maternal and child health and family stability. Few interventions are specifically designed to address this significant public health problem. The Parent–Child Assistance Program (PCAP) is a 3-year case management and home-visiting intervention that seeks to help birthing persons with at-risk substance use during pregnancy to achieve and maintain substance use disorder recovery and avoid exposing future children to substances prenatally. At-risk refers to a level of substance use that creates problems in the individuals’ lives or puts them or their children at risk of harm either prenatally or postnatally. Although the program has consistently shown substantial pre- to post-intervention improvements in its participants, PCAP remains to be tested with a rigorous randomized controlled trial (RCT). This study protocol describes a randomized controlled trial that aims to examine the effectiveness of the intervention compared to services as usual in affecting primary outcomes related to substance use and family planning. Secondary outcomes will concern connection to recovery support services and family preservation.

Methods

Using an intent-to-treat design, the study will recruit from two metro areas in Oklahoma and enroll 200 birthing individuals who are pregnant or up to 24 months postpartum with at-risk substance use during their current or most recent pregnancy. Participants will be randomly assigned, stratified by location, to receive either PCAP or services as usual for 3 years. Participants in the PCAP condition will meet with their case manager approximately biweekly over the course of the intervention period, in their local communities or in their own homes whenever possible. Case managers will assist with goal setting and provide practical assistance in support of participants’ goals. Primary and secondary outcomes will be assessed at baseline and 12, 24, and 36 months post-baseline using the Addiction Severity Index interview and a self-administered survey.

Discussion

Results from this trial will help to gauge the effectiveness of PCAP in improving parent and child well-being. Results will be reviewed by federal clearinghouses on home-visiting and foster care prevention to determine the strength of evidence of effectiveness with implications for federal financing of this program model at the state level.

Trial registration

ClinicalTrials.gov NCT05534568. Registered on 6/8/2022.
Appendix
Available only for authorised users
Literature
1.
go back to reference Logue TC, Wen T, Friedman AM. Demographic trends associated with substance use disorder and risk for adverse obstetric outcomes with cannabis and opioid use disorders. J Matern Fetal Neonatal Med. 2022;35(26):2128658.CrossRefPubMed Logue TC, Wen T, Friedman AM. Demographic trends associated with substance use disorder and risk for adverse obstetric outcomes with cannabis and opioid use disorders. J Matern Fetal Neonatal Med. 2022;35(26):2128658.CrossRefPubMed
2.
go back to reference Salemi JL, Raza SA, Modak S, Fields-Gilmore JAR, Mejia de Grubb MC, Zoorob RJ. The association between use of opiates, cocaine, and amphetamines during pregnancy and maternal postpartum readmission in the United States: a retrospective analysis of the Nationwide Readmissions Database. Drug Alcohol Depend. 2020;210:107963.CrossRefPubMed Salemi JL, Raza SA, Modak S, Fields-Gilmore JAR, Mejia de Grubb MC, Zoorob RJ. The association between use of opiates, cocaine, and amphetamines during pregnancy and maternal postpartum readmission in the United States: a retrospective analysis of the Nationwide Readmissions Database. Drug Alcohol Depend. 2020;210:107963.CrossRefPubMed
3.
go back to reference Oni HT, Buultjens M, Mohamed AL, Islam MM. Neonatal outcomes of infants born to pregnant women with substance use disorders: a multilevel analysis of linked data. Subst Use Misuse. 2022;57(1):1–10.CrossRefPubMed Oni HT, Buultjens M, Mohamed AL, Islam MM. Neonatal outcomes of infants born to pregnant women with substance use disorders: a multilevel analysis of linked data. Subst Use Misuse. 2022;57(1):1–10.CrossRefPubMed
4.
go back to reference Umer A, Watson E, Lilly C, Woods S, Lefeber C, Breyel J, et al. Substance exposure and adverse neonatal outcomes: a population-based cohort study. J Pediatr. 2023;256:70–6.CrossRefPubMed Umer A, Watson E, Lilly C, Woods S, Lefeber C, Breyel J, et al. Substance exposure and adverse neonatal outcomes: a population-based cohort study. J Pediatr. 2023;256:70–6.CrossRefPubMed
7.
go back to reference Lynch V, Clemans-Cope L, Howell E, Hill I. Diagnosis and treatment of substance use disorder among pregnant women in three state Medicaid programs from 2013 to 2016. J Subst Abuse Treat. 2021;124:108265.CrossRefPubMed Lynch V, Clemans-Cope L, Howell E, Hill I. Diagnosis and treatment of substance use disorder among pregnant women in three state Medicaid programs from 2013 to 2016. J Subst Abuse Treat. 2021;124:108265.CrossRefPubMed
8.
go back to reference Forray A, Merry B, Lin H, Ruger JP, Yonkers KA. Perinatal substance use: a prospective evaluation of abstinence and relapse. Drug Alcohol Depend. 2015;1(150):147–55.CrossRef Forray A, Merry B, Lin H, Ruger JP, Yonkers KA. Perinatal substance use: a prospective evaluation of abstinence and relapse. Drug Alcohol Depend. 2015;1(150):147–55.CrossRef
9.
10.
go back to reference Ecker J, Abuhamad A, Hill W, Bailit J, Bateman BT, Berghella V, et al. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the society for maternal-fetal medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Am J Obstet Gynecol. 2019;221(1):B5–28.CrossRefPubMed Ecker J, Abuhamad A, Hill W, Bailit J, Bateman BT, Berghella V, et al. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the society for maternal-fetal medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Am J Obstet Gynecol. 2019;221(1):B5–28.CrossRefPubMed
11.
go back to reference Nidey N, Kair LR, Wilder C, Froehlich TE, Weber S, Folger A, et al. Substance use and utilization of prenatal and postpartum care. J Addict Med. 2022;16(1):84–92.CrossRefPubMedPubMedCentral Nidey N, Kair LR, Wilder C, Froehlich TE, Weber S, Folger A, et al. Substance use and utilization of prenatal and postpartum care. J Addict Med. 2022;16(1):84–92.CrossRefPubMedPubMedCentral
12.
go back to reference Comtois KA, Schiff MA, Grossman DC. Psychiatric risk factors associated with postpartum suicide attempt in Washington State, 1992–2001. Am J Obstet Gynecol. 2008;199(2):120.e1–5.CrossRefPubMed Comtois KA, Schiff MA, Grossman DC. Psychiatric risk factors associated with postpartum suicide attempt in Washington State, 1992–2001. Am J Obstet Gynecol. 2008;199(2):120.e1–5.CrossRefPubMed
13.
go back to reference Bruce BB, Biousse V, Dean AL, Newman NJ. Neurologic and ophthalmic manifestations of fetal alcohol syndrome. Rev Neurol Dis. 2009;6(1):13–20.PubMed Bruce BB, Biousse V, Dean AL, Newman NJ. Neurologic and ophthalmic manifestations of fetal alcohol syndrome. Rev Neurol Dis. 2009;6(1):13–20.PubMed
14.
go back to reference Williams JF, Smith VC. Committee on substance abuse. Fetal Alcohol Spectr Disord Pediatr. 2015;136(5):e1395–1406. Williams JF, Smith VC. Committee on substance abuse. Fetal Alcohol Spectr Disord Pediatr. 2015;136(5):e1395–1406.
15.
go back to reference Greenmyer JR, Popova S, Klug MG, Burd L. Fetal alcohol spectrum disorder: a systematic review of the cost of and savings from prevention in the United States and Canada. Addiction. 2020;115(3):409–17.CrossRefPubMed Greenmyer JR, Popova S, Klug MG, Burd L. Fetal alcohol spectrum disorder: a systematic review of the cost of and savings from prevention in the United States and Canada. Addiction. 2020;115(3):409–17.CrossRefPubMed
16.
go back to reference Bayrampour H, Zahradnik M, Lisonkova S, Janssen P. Women’s perspectives about cannabis use during pregnancy and the postpartum period: an integrative review. Prev Med. 2019;119:17–23.CrossRefPubMed Bayrampour H, Zahradnik M, Lisonkova S, Janssen P. Women’s perspectives about cannabis use during pregnancy and the postpartum period: an integrative review. Prev Med. 2019;119:17–23.CrossRefPubMed
17.
go back to reference Gray TR, Eiden RD, Leonard KE, Connors GJ, Shisler S, Huestis MA. Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin Chem. 2010;56(9):1442–50.CrossRefPubMedPubMedCentral Gray TR, Eiden RD, Leonard KE, Connors GJ, Shisler S, Huestis MA. Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin Chem. 2010;56(9):1442–50.CrossRefPubMedPubMedCentral
18.
go back to reference Corsi DJ, Hsu H, Fell DB, Wen SW, Walker M. Association of maternal opioid use in pregnancy with adverse perinatal outcomes in Ontario, Canada, from 2012 to 2018. JAMA Netw Open. 2020;3(7):e208256.CrossRefPubMed Corsi DJ, Hsu H, Fell DB, Wen SW, Walker M. Association of maternal opioid use in pregnancy with adverse perinatal outcomes in Ontario, Canada, from 2012 to 2018. JAMA Netw Open. 2020;3(7):e208256.CrossRefPubMed
19.
20.
go back to reference Gouin K, Murphy K, Shah PS, Knowledge Synthesis group on Determinants of Low Birth Weight and Preterm Births. Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses. Am J Obstet Gynecol. 2011;204(4):340.e1–12.CrossRefPubMed Gouin K, Murphy K, Shah PS, Knowledge Synthesis group on Determinants of Low Birth Weight and Preterm Births. Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses. Am J Obstet Gynecol. 2011;204(4):340.e1–12.CrossRefPubMed
21.
go back to reference Sankaran D, Lakshminrusimha S, Manja V. Methamphetamine: burden, mechanism and impact on pregnancy, the fetus, and newborn. J Perinatol. 2022;42(3):293–9.CrossRefPubMed Sankaran D, Lakshminrusimha S, Manja V. Methamphetamine: burden, mechanism and impact on pregnancy, the fetus, and newborn. J Perinatol. 2022;42(3):293–9.CrossRefPubMed
25.
go back to reference Ernst CC, Grant TM, Streissguth AP, Sampson PD. Intervention with high-risk alcohol and drug-abusing mothers: II. Three-year findings from the Seattle model of paraprofessional advocacy. J Community Psychol. 1999;27(1):19–38.CrossRef Ernst CC, Grant TM, Streissguth AP, Sampson PD. Intervention with high-risk alcohol and drug-abusing mothers: II. Three-year findings from the Seattle model of paraprofessional advocacy. J Community Psychol. 1999;27(1):19–38.CrossRef
26.
go back to reference Hildebrandt UC, Graham JC, Grant TM. Predictors and moderators of improved social-emotional functioning in mothers with substance use disorders and their young children enrolled in a relationship-based case management program. Infant Ment Health J. 2020;41(5):677–96.CrossRefPubMed Hildebrandt UC, Graham JC, Grant TM. Predictors and moderators of improved social-emotional functioning in mothers with substance use disorders and their young children enrolled in a relationship-based case management program. Infant Ment Health J. 2020;41(5):677–96.CrossRefPubMed
28.
go back to reference Grant T, Ernst CC, Pagalilauan G, Streissguth A. Postprogram follow-up effects of paraprofessional intervention with high-risk women who abused alcohol and drugs during pregnancy. J Community Psychol. 2003;31(3):211–22.CrossRef Grant T, Ernst CC, Pagalilauan G, Streissguth A. Postprogram follow-up effects of paraprofessional intervention with high-risk women who abused alcohol and drugs during pregnancy. J Community Psychol. 2003;31(3):211–22.CrossRef
29.
go back to reference Surrey JL. Self-in-relation: a theory of women’s development. 1985. Surrey JL. Self-in-relation: a theory of women’s development. 1985.
30.
go back to reference Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38–48.CrossRefPubMed Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38–48.CrossRefPubMed
32.
go back to reference Urbaniak GC, Plous S. Research randomizer (version 4.0)[computer software]. 2013. Urbaniak GC, Plous S. Research randomizer (version 4.0)[computer software]. 2013.
33.
go back to reference McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The fifth edition of the addiction severity index. J Subst Abuse Treat. 1992;9(3):199–213.CrossRefPubMed McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The fifth edition of the addiction severity index. J Subst Abuse Treat. 1992;9(3):199–213.CrossRefPubMed
35.
go back to reference Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. J Pers Assess. 1988;52(1):30–41.CrossRef Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. J Pers Assess. 1988;52(1):30–41.CrossRef
36.
go back to reference Ertmann RK, Bang CW, Kriegbaum M, Væver MS, Kragstrup J, Siersma V, et al. What factors are most important for the development of the maternal-fetal relationship? A prospective study among pregnant women in Danish general practice. BMC Psychol. 2021;9(1):2.CrossRefPubMedPubMedCentral Ertmann RK, Bang CW, Kriegbaum M, Væver MS, Kragstrup J, Siersma V, et al. What factors are most important for the development of the maternal-fetal relationship? A prospective study among pregnant women in Danish general practice. BMC Psychol. 2021;9(1):2.CrossRefPubMedPubMedCentral
37.
go back to reference Bird PK, Hindson Z, Dunn A, Cronin de Chavez A, Dickerson J, Howes J, et al. Implementing the Maternal Postnatal Attachment Scale (MPAS) in universal services: qualitative interviews with health visitors. Wellcome Open Res. 2022;7:85.CrossRefPubMed Bird PK, Hindson Z, Dunn A, Cronin de Chavez A, Dickerson J, Howes J, et al. Implementing the Maternal Postnatal Attachment Scale (MPAS) in universal services: qualitative interviews with health visitors. Wellcome Open Res. 2022;7:85.CrossRefPubMed
38.
go back to reference Hansen M, Andersen TE, Armour C, Elklit A, Palic S, Mackrill T. PTSD-8: a short PTSD inventory. Clin Pract Epidemiol Ment Health. 2010;28(6):101–8.CrossRef Hansen M, Andersen TE, Armour C, Elklit A, Palic S, Mackrill T. PTSD-8: a short PTSD inventory. Clin Pract Epidemiol Ment Health. 2010;28(6):101–8.CrossRef
39.
go back to reference Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60(2):184–9.CrossRefPubMed Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60(2):184–9.CrossRefPubMed
40.
go back to reference Rosenberg M. Rosenberg self-esteem scale (RSE). Accept Commitment Ther Meas Package. 1965;61(52):18. Rosenberg M. Rosenberg self-esteem scale (RSE). Accept Commitment Ther Meas Package. 1965;61(52):18.
41.
go back to reference Chen G, Gully SM, Eden D. Validation of a New general self-efficacy scale. Organ Res Methods. 2001;4(1):62–83.CrossRef Chen G, Gully SM, Eden D. Validation of a New general self-efficacy scale. Organ Res Methods. 2001;4(1):62–83.CrossRef
42.
go back to reference Humphreys K, Greenbaum MA, Noke JM, Finney JW. Reliability, validity, and normative data for a short version of the understanding of alcoholism scale. Psychol Addict Behav. 1996;10(1):38–44.CrossRef Humphreys K, Greenbaum MA, Noke JM, Finney JW. Reliability, validity, and normative data for a short version of the understanding of alcoholism scale. Psychol Addict Behav. 1996;10(1):38–44.CrossRef
43.
go back to reference Luke DA, Ribisl KM, Walton MA, Davidson WS. Assessing the diversity of personal beliefs about addiction: development of the addiction belief inventory. Subst Use Misuse. 2002;37(1):89–120.CrossRefPubMed Luke DA, Ribisl KM, Walton MA, Davidson WS. Assessing the diversity of personal beliefs about addiction: development of the addiction belief inventory. Subst Use Misuse. 2002;37(1):89–120.CrossRefPubMed
45.
go back to reference Narayan A, Ghosh Ippen C, Rivera L, Lieberman A. The benevolent childhood experiences (BCEs) scale. San Francisco: Department of Psychiatry, University of California; 2015. Narayan A, Ghosh Ippen C, Rivera L, Lieberman A. The benevolent childhood experiences (BCEs) scale. San Francisco: Department of Psychiatry, University of California; 2015.
47.
go back to reference Lachin JM. Statistical considerations in the intent-to-treat principle. Control Clin Trials. 2000;21(3):167–89.CrossRefPubMed Lachin JM. Statistical considerations in the intent-to-treat principle. Control Clin Trials. 2000;21(3):167–89.CrossRefPubMed
Metadata
Title
Study protocol for a randomized controlled trial of the Parent–Child Assistance Program: a case management and home visiting program for people using substances during pregnancy
Authors
Erin J. Maher
Susan A. Stoner
Julie Gerlinger
A. C. Ferraro
Heather Lepper-Pappan
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Trials / Issue 1/2024
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-024-08098-6

Other articles of this Issue 1/2024

Trials 1/2024 Go to the issue